Royalty Pharma plc
Royalty Pharma plc (RPRX) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
rprx · stock forecast · 11 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 11 Wall Street analysts in the past 3 months
Buy
11 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$63.00
Consensus
$53.75
-3.8% upside
Low
$45.00
Median: $53.5 · Last Close: $55.87
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Consensus Target
$53.75
-3.8% upside
High Target
$63
12.8%
Low Target
$45
-19.5%
Current Price
$55.87
as of today
Based on analyst price targets, the RPRX stock price prediction for the next 12 months ranges from $45 to $63. The consensus RPRX price forecast of $53.75 implies -3.8% upside from the current price of $55.87.
Short-Term Price Prediction
BullAlgorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $57.11 | ↑ 2.23% |
1-day model range: $56.98–$57.25. Peak: $57.25 (+2.23%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $75 | +34.0% |
| 2028 | $91 | +63.6% |
| 2029 | $105 | +87.1% |
| 2030 | $114 | +104.5% |
| 2031 | — | +116.9% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BULLISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · RPRX · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-07 | Citigroup | Maintains | Buy→Buy |
| 2026-05-07 | JP Morgan | Maintains | Overweight→Overweight |
| 2026-04-21 | UBS | Maintains | Buy→Buy |
| 2026-04-10 | Morgan Stanley | Maintains | Overweight→Overweight |
| 2026-01-30 | UBS | Upgrade ↑ | Neutral→Buy |
| 2026-01-27 | Citigroup | Maintains | Buy→Buy |
| 2025-12-11 | TD Cowen | Maintains | Buy→Buy |
| 2025-10-10 | Morgan Stanley | Maintains | Overweight→Overweight |
| 2025-07-22 | Citigroup | Maintains | Buy→Buy |
| 2025-07-10 | Morgan Stanley | Maintains | Overweight→Overweight |
Wall Street analysts have recently issued updated ratings on Royalty Pharma plc (RPRX) stock. Of the recent 45 rating actions, 5 were upgrades and 1 were downgrades. 11 analysts currently cover RPRX.
Analyst Recommendation Trends
RPRX analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 2 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$3.5B
↓ 14.2% YoY
Revenue Next Year
$3.7B
↑ 7.5% YoY
EPS This Year
$5.13
EPS Next Year
$5.62
↑ 9.6% YoY
EPS ForecastReported vs Estimated
Analysts forecast RPRX EPS of $5.13 for the current fiscal year, based on estimates from 4 analysts. The RPRX revenue forecast is $3.5B for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The RPRX stock forecast is supported by two independent data sources: analyst consensus ratings from 11 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus RPRX price target is $53.75 (-3.8% upside), with an analyst consensus of Buy.
The RPRX short-term stock prediction for tomorrow is $57.11 (+2.23%). The RPRX stock price prediction for 2027 estimates an average of $75. The RPRX stock prediction for 2030 projects a range of $111–$117.
Royalty Pharma plc trades on NASDAQ under the ticker RPRX. The RPRX stock outlook for 2027 is broadly positive, supported by a Buy consensus among 100% of covering analysts.
Frequently asked questions
RPRX forecast · 8 questionsAccording to 11 Wall Street analysts, the average 12-month RPRX price target is $53.75, with a high forecast of $63.00 and a low of $45.00. The median price target is shown in the chart above when available. This implies -3.8% potential upside from the current price of $55.87.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.